Literature DB >> 24062273

Clinical characteristics and lung function in chronic obstructive pulmonary disease complicated with impaired peripheral oxygenation.

Ming-Lung Chuang1, I-Feng Lin.   

Abstract

During exercise testing, patients with chronic obstructive pulmonary disease (COPD) often present with ventilatory limitations and various combinations of impaired peripheral oxygenation (IPO) to the exercising muscles. The entities of IPO include anemia, circulation impairment and deconditioning. COPD-IPO is not widely accepted as being a subgroup of COPD. Therefore, the aim of this study was to evaluate the clinical features of COPD-IPO patients. Forty-seven COPD patients underwent cardiopulmonary exercise testing. COPD-IPO was identified when all IPO variables had abnormal values. The patients who did not meet the COPD-IPO criteria were defined as the NIPO group. The variables with abnormal values included peak oxygen uptake (VO₂) <85% predicated, anaerobic threshold <40% VO₂max pred, VO₂-work rate slope <8.6 ml/watt, oxygen pulse <80%pred, and ventilatory equivalents for O₂ and CO₂ at nadir (>31 and >34, respectively). Anthropometrics, biochemistry, and lung function were compared between the groups. Forty-six COPD patients were enrolled after excluding one patient who had technical difficulties in performing the exercise tests. Despite FEV1 and FVC being similarly reduced (p = NS) between the groups, the COPD-IPO (n = 13, 28%) patients had lower body mass index and were taller, and had impaired diffusing capacity and larger total lung capacity and air-trapping (all p < 0.05). We concluded that COPD patients with all six variables having abnormal values are a unique subgroup and that identification of these patients is worthwhile for further investigations and management such as exercise training and nutritional supplements.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24062273     DOI: 10.1007/s11739-013-0989-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  25 in total

1.  Effects of emphysema and lung volume reduction surgery on transdiaphragmatic pressure and diaphragm length.

Authors:  François Bellemare; Marie-Pierre Cordeau; Jacques Couture; Edwin Lafontaine; Pierre Leblanc; Louise Passerini
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

2.  ATS/ERS Statement on respiratory muscle testing.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405

3.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

4.  Use of cluster analysis to define COPD phenotypes.

Authors:  M Weatherall; P Shirtcliffe; J Travers; R Beasley
Journal:  Eur Respir J       Date:  2010-09       Impact factor: 16.671

5.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

6.  Pulmonary rehabilitation improves exercise capacity and quality of life in underweight patients with chronic obstructive pulmonary disease.

Authors:  Chou-Chin Lan; Mei-Chen Yang; Chih-Hsin Lee; Yi-Chih Huang; Chun-Yao Huang; Kuo-Liang Huang; Yao-Kuang Wu
Journal:  Respirology       Date:  2011-02       Impact factor: 6.424

7.  Predicted values for clinical exercise testing.

Authors:  J E Hansen; D Y Sue; K Wasserman
Journal:  Am Rev Respir Dis       Date:  1984-02

8.  Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.

Authors:  C R McGavin; M Artvinli; H Naoe; G J McHardy
Journal:  Br Med J       Date:  1978-07-22

9.  Effect of reduced body weight on muscle aerobic capacity in patients with COPD.

Authors:  P Palange; S Forte; P Onorati; V Paravati; F Manfredi; P Serra; S Carlone
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

10.  Value of chest radiography in phenotyping chronic obstructive pulmonary disease.

Authors:  M Miniati; S Monti; J Stolk; G Mirarchi; F Falaschi; R Rabinovich; C Canapini; J Roca; K F Rabe
Journal:  Eur Respir J       Date:  2007-12-05       Impact factor: 16.671

View more
  6 in total

1.  Exercise-mediated reactive oxygen species generation in athletes and in patients with chronic disease.

Authors:  Gianni Biolo; Filippo Giorgio Di Girolamo; Nicola Fiotti; Filippo Mearelli; Patrizio Sarto
Journal:  Intern Emerg Med       Date:  2017-05-31       Impact factor: 3.397

2.  Resting Dead Space Fraction as Related to Clinical Characteristics, Lung Function, and Gas Exchange in Male Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Ming-Lung Chuang; Benjamin Yung-Thing Hsieh; I-Feng Lin
Journal:  Int J Gen Med       Date:  2021-02-03

3.  Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation.

Authors:  Ming-Lung Chuang; Shih-Feng Huang; Chun-Hung Su
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-11

4.  Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease--A Randomized Placebo Controlled Double Blind Clinical Trial.

Authors:  Ming-Lung Chuang; Tzu-Chin Wu; Yau-Tung Wang; Yau-Chen Wang; Thomas C-Y Tsao; James Cheng-Chung Wei; Chia-Yin Chen; I-Feng Lin
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

5.  More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease.

Authors:  Ming-Lung Chuang; I-Feng Lin; Meng-Jer Hsieh
Journal:  J Clin Med       Date:  2019-10-07       Impact factor: 4.241

6.  Tidal volume expandability affected by flow, dynamic hyperinflation, and quasi-fixed inspiratory time in patients with COPD and healthy individuals.

Authors:  Ming-Lung Chuang
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.